ANVS
ANVS
NYSE · Biotechnology

Annovis Bio

$0.84
+0.10 (+13.16%)
As of Nov 18, 10:10 PM ET ·
Day Range $0.74 — $0.84
52W Range $0.62 — $5.50
Open$0.77
Previous Close$0.74
Day High$0.84
Day Low$0.74
52W High$5.50
52W Low$0.62
Volume—
Avg Volume5.88M
Market Cap39.28M
P/E Ratio—
EPS$-1.78
SectorBiotechnology

Analyst Ratings

Strong Buy
10 analysts
9 Buy 1 Hold 0 Sell
Price Target +1,619.4% upside
Current
$0.84
Target
$14.46
$8.98 $14.46 avg $17.59

Key Financials

FY 2025 FY 2024 FY 2023
Revenue 18.60M 19.31M 20.88M
Net Income -5,133,777 -5,587,628 -4,631,912
Profit Margin -27.6% -28.9% -22.2%
EBITDA -5,451,350 -5,303,939 -6,015,367
Free Cash Flow -4,165,501 -4,081,500 -5,685,079
Rev Growth +22.8% -8.3% +12.1%
Debt/Equity 0.56 0.49 0.59

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $286.01 -2.33% 50.3 520.47B
AMGN Amgen Inc $443.89 -3.07% 26.9 252.64B
GILD Gilead Sciences Inc $168.98 -0.75% — 208.95B
VRTX Vertex Pharmaceuticals Inc $536.45 +0.42% 33.9 134.82B
REGN Regeneron Pharmaceuticals $945.53 -1.28% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $149.40 -4.54% 7.7 20.98B

ANVS News

No news for ANVS yet

Quick Stats

Market Cap39.28M
P/E Ratio—
EPS$-1.78
Volume—
SectorBiotechnology